Asymmetric synthesis of carbon-11 labelled α-amino acids for PET

Current Organic Chemistry

Volumn 17, Issue 19, 2013, Pages 2127-2137

  Popkov, Alexander ^a   Elsinga, Philip H ^b  

^a UNIVERSITY OF PARDUBICE   (Czech Republic)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Amino acids; Asymmetric synthesis; Carbon 11; Neurotransmitters; Positron emission tomography; Radiolabelling; Tumour

Indexed keywords

AMINO ACIDS; BIOSYNTHESIS; CARBON; DIAGNOSIS; HYDROGENATION; LACTIC ACID; TUMORS;

AMINO-ACIDS; ASYMMETRIC SYNTHESIS; CARBON-11; IN-VIVO MEASUREMENT; MEASUREMENTS OF; MEMBRANE TRANSPORT; NEUROTRANSMITTER; RADIOLABELLING; SYNTHONS; TRANSPORT SYSTEMS;

POSITRON EMISSION TOMOGRAPHY;

EID: 84893166309     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/13852728113179990105     Document Type: Review

References (148)

1. Pieterman, R.M.; van Putten, J.W.; Meuzelaar, J.J.; Mooyaart, E.L.; Vaalburg, W.; Koeter, G.H.; Fidler, V.; Pruim, J.; Groen, H.J.M Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N. Engl. J. Med., 2000, 343, 254-261.
2. Spence, A.M.; Muzi, M.; Graham, M.M.; O'Sullivan, F.; Krohn, K.A.; Link, J.M.; Lewellen, T.K.; Lewellen, B.; Freeman S.D.; Berger M.S.; Ojemann, G.A. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: Analysis of the FDG lumped constant. J. Nucl. Med., 1998, 39, 440-448.
3. Kole, A.C.; Plaat, B.E.; Hoekstra, H.J.; Vaalburg, W.; Molenaar, W.M. FDG and L-[1-C-11]-tyrosine imaging of soft-tissue tumors before and after therapy. J. Nucl. Med., 1999, 40, 381-386.
4. Weber, W.A.; Wester, H.J.; Grosu, A.L.; Herz, M.; Dzewas, B.; Feldmann, H.J.; Molls, M.; Stocklin, G.; Schwaiger M. O-(2-[F-18]fluoroethyl)-Ltyrosine and L-[methyl-C-11]methionine uptake in brain tumours: initial results of a comparative study. Eur. J. Nucl. Med., 2000, 27, 542-549.
5. Jager, P. L.; Vaalburg, W., Pruim, J.; de Vries, E.G.E.; Langen, K.J.; Piers, D.A. Radiolabeled amino acids: Basic aspects and clinical applications in on cology. J. Nucl. Med., 2001, 42, 432-445.
6. Lahorte, C.M.M.; Vanderheyden, J.L.; Steinmetz, N.; van de Wiele, C.; Dierckx, R.A.; Slegers, G. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur. J. Nucl. Med., 2004, 31, 887-919.
7. Krohn, K.A.; Mankoff, D.A.; Eary, J.F. Imaging cellular proliferation as a measure of response to therapy. J. Clin. Pharmacol., 2001, S96-S103.
8. Bading, J.R.; Alauddin, M.M.; Fissekis, J.D.; Shahinian, A.H.; Joung, J.; Spector, T.; Conti P.S. Blocking catabolism with eniluracil enhances PET studies of 5-[F-18]fluorouracil pharmacokinetics. J. Nucl. Med., 2000, 41, 1714-1724.
9. Been, L.B.; Suurmeijer, A.J.H.; Cobben, D.C.P.; Jager, P.L.; Hoekstra, H.J.; Elsinga, P.H. [F-18]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging., 2004, 31, 1659-1672.
10. de Jong, I.J.; Pruim, J.; Elsinga, P.H.; Vaalburg, W.; Mensink, H.J.A. C-11-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur. Urol., 2003, 44, 32-38.
11. Hara, T. F-18-fluorocholine: A new oncologic PET tracer. J. Nucl. Med., 2001, 42, 1815-1817.
12. Souvatzoglou, M.; Grosu, A.L.; Röper, B.; Krause, B.J.; Beck, R.; Reischl, G.; Picchio, M., Machulla, H.J.; Wester, H.J.; Piert, M. Tumour hypoxia imaging with [F-18]FAZA PET in head and neck cancer patients: a pilot study. Eur. J. Nucl. Med., 2007, 34, 1566-1575.
13. Wester, H.J.; Schottelius, M.; Scheidhauer, K.; Meisetschlager, G.; Herz, M., Rau, F.C.; Reubi, J.C.; Schwaiger, M. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel F-18-labelled, carbohydrated analogue of octreotide. Eur. J. Nucl. Med., 2003, 30, 117-122.
14. Jonson, S.D.; Welch, M.J. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins. Q. J. Nucl. Med., 1998, 42, 8-17.
15. Varagnolo, L.; Stokkel, M.P.; Mazzi, U.; Pauwels, E.K. F-18-labeled radio-pharmaceuticals for PET in oncology, excluding FDG. Nucl. Med. Biol., 2000, 27, 103-112.
16. Madar, I.; Weiss, L.; Izbicki, G. Preferential accumulation of H-3-tetraphenylphosphonium in non-small cell lung carcinoma in mice: Comparison with Tc-99 m-MIBI. J. Nucl. Med., 2002, 43, 234-238.
17. Koopmans, K.P.; de Vries E.G.E.; Kema, I.P.; Elsinga, P.H.; Neels, O.C.; Sluiter, W.J.; van der Horst-Schrivers, A.N.A.; Jager, P.L. Staging of carcinoid tumours with F-18-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncology, 2006, 7, 728-734.
18. Neels, O.C.; Jager, P.L.; Koopmans, K.P.; Eriks, E.; de Vries, E.G.E.; Kema, I.P.; Elsinga, P. H. Develoment of a reliable remote-controlled synthesis of beta-[C-11]-5-hydroxy-L-tryptophan on a Zymark robotic system. J. Lab. Compnds. Radiopharm., 2006, 49, 889-895.
19. 18F]FLT-PET in oncology: current status and opportunities. Eur. J. Nucl. Med. Mol. Imaging., 2004, 31, 1659-1672.
20. 18F-fluoride PET/CT in benign and malignant bone diseases. Bone, 2012, 50, 128-139.
21. Castellucci, P.; Jadvar, H. PET/CT in prostate cancer: non-choline radiopharmaceuticals. Q. J. Nucl. Med. Mol. Imaging., 2012, 56, 367-374.
22. Vangestel, C.; Peeters, M.; Mees, G.; Oltenfreiter, R.; Boersma, H.H.; Elsinga, P.H.; Reutelingsperger, C.; Van Damme, N.; De Spiegeleer, B.; Van de Wiele, C. In vivo imaging of apoptosis in oncology: an update. Mol. Imaging, 2011, 10, 340-358.
23. 64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]MISO - a selected review. Nucl. Med. Rev. Cent. East Eur., 2011, 14, 90-95.
24. 18Ffluorodihydrotestosterone, a new radiotracer for imaging prostate cancer. J. Nucl. Med., 2004, 45, 1966-1971.
25. Nordberg A. Amyloid imaging in Alzheimer's disease. Curr. Opin. Neurol., 2007, 20, 398-402.
26. 11C]PK11195 challengers. Eur. J. Nucl. Med. Mol. Imaging., 2008, 35, 2304-2319.
27. Virdee, K.; Cumming, P.; Caprioli, D.; Jupp, B.; Rominger, A.; Aigbirhio, F.I.; Fryer, T.D.; Riss, P.J.; Dalley, J.W. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders. Neuroscience and Biobehavioral Reviews, 2012, 36, 1188-1216.
28. Popkov, A.; Blahutova, A.; Kanova, M. Can 6-[F-18]fluoroDOPA be an accurate alternative for beta-[C-11]DOPA? J. Lab. Compnds. Radiopharm., 2007, 50, 528-529.
29. Matsubara, K.; Watabe, H.; Kumakura, Y.; Hayashi, T.; Enders, C.J.; Minato, K.; Iida, H. Sensitivity of Kinetic Macro Parameters to Changes in Dopamine Synthesis, Storage, and Metabolism: A Simulation Study for [F-18]FDOPA PET By a Model With Detailed Dopamine Pathway. Synapse, 2011, 65, 751-762.
30. Kumakura, Y.; Vernaleken, I.; Buchholz, H.-G.; Borghammera, P.; Danielsen, E.; Grunder, G.; Heinz, A.; Bartenstein, P.; Cumming, P. Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study. Neurobiology of Aging, 2010, 31, 447-463.
31. Schiepers, C.; Chen, W.; Cloughesy, T.; Dahlbom, M.; Huang, S.-C. F-18-FDOPA kinetics in brain tumors. J. Nucl. Med., 2007, 48, 1651-1661.
32. McConathy, J.Y.W.; Jarkas, N.; Seo, W.; Schuster, D.M.; Goodman, M.M. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents. Med. Res. Rev. 2012, 32, 868-905.
33. 18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis. J. Nucl Med. 2012, 53, 207-214.
34. 11C-labelled amino acids. PhD Thesis, Uppsala University: Uppsala. Acta Universitatis Upsaliensis, 1995.
35. Willemsen, A.T.; van Waarde, A.; Paans, A.M.; Pruim, J.; Luurtsema, G.; Go, K.G.; Vaalburg, W. In-vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-C-11]-tyrosine and PET. J. Nucl. Med., 1995, 36, 411-419.
36. Axelrod, J.; Weisbach, H. Enzymatic O-methylation of N-acetylserotonin to melatonin. Science, 1960, 131, 1312.
37. Roberge, A.; Missala, K.; Sourkes, T.L. Alpha-methyltryptophan - effects on synthesis and degradation of serotonin in brain. Neuropharmacology, 1972, 11, 197-209.
38. Sugden, D. Melatonin biosynthesis in the mammalian pineal gland. Experentia, 1989, 45, 923-932.
39. Banker, G.; Cotman, C.W. Characteristics of different amino acids as protein precursors in mouse brain - advantages of certain carxyl-labeled amino acids. Arch. Biochem. Biophys., 1971, 142, 565.
40. Daemen, B.J.G.; Elsinga, P.H.; Paans, A.M.J.; Lemstra, W.; Konings, A.W.T.; Vaalburg, W. Suitability of rodent tumor models for experimental PET with L-[1-C-11]tyrosine and 2-[F-18]fluoro-2-deoxy-D-glucose. Nucl. Med. Biol., 1991, 18, 503-511.
41. Jager, P.L.; Groen, H.J.M.; van der Leest, A.; van Putten, J.W.G.; Pieterman, R.M.; de Vries, E.G.E.; Piers, D.A. L-3-[I-123]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: Preliminary observations. J. Nucl. Med., 2001, 42, 579-585.
42. Antoni, G.; Kihlberg, T.; Långström, B. In: Handbook of Radiopharmaceuticals; Welch M. J. and Redvanly C. S., Eds.; Wiley: Chichester, 2003; ch. 5, pp. 151-153, 164-166.
43. Cramer, R.D.; Kistiakowsky, G.B. The synthesis of radioactive lactic acid. J. Biol. Chem., 1941, 137, 549-555.
44. Drandarov, K.; Schubiger, P.A.; Westera, G. Automated no-carrieradded synthesis of [1-C-11]-labeled D-and L-enantiomers of lactic acid. Appl. Radiat. Isot., 2006, 64, 1613-1622.
45. Weimer, K. PhD Thesis, University of Darmstadt, 1973.
46. Vaalburg, W.; Strating, M.G.; Woldring, M.G.; Wynberg, H. Rapid synthesis of alpha phenyl glycine by carboxylation of alpha lithiobenzyl isocyanide. Synth. Commun., 1972, 2, 423-425 (this article describes preparation of the non-labelled amino acid).
47. Vaalburg, W.; Beerling-van der Molen, H.D.; Reiffers, S.; Rijskamp, A.; Woldring, M.G.; Wynberg, H. Preparation of carbon-11 labelled phenylalanine and phenylglycine by a new aminoacid synthesis. Int. J. Appl. Radiat. Isot., 1976, 27, 153-157.
48. Vaalburg, W.; Beerling-van der Molen, H.D.; Woldring, M.G. Evaluation of carbon-11 labeled phenylglycine and phenylalanine for pancreas scintigraphy. Nuclearmedizin, 1975, 14, 60-66.
49. Reiffers, S.; Beerling-van der Molen, H.D.; Vaalburg, W.; Ten Hoeve, W.;Paans, A.M.J.; Korf, J.; Woldring, M.G.; Wynberg, H. Rapid synthesis and purification of C-11 labeled DOPA - potential agent for brain studies. Int. J. Appl. Radiat. Isot., 1977, 28, 955-958.
50. Luurtsema, G.; Medema, J.; Elsinga, P.H.; Visser, G.M.; Vaalburg W. Robotic synthesis of L-[1-C-11]tyrosine. Appl. Radiat. Isot., 1994, 45, 821-828.
51. Bolster, J.M.; Vaalburg, W.; Paans, A.M.J.; van Dijk, Th. H.; Elsinga, P.H.; Zijlstra, J.B.; Piers, D.A.; Mulder, N.H.; Woldring, M.G.; Wynberg, H. C-11 labeled tyrosine to study tumor metabolism by positron emission tomography (PET). Eur. J. Nucl. Med., 1986, 12, 321-324.
52. Halldin, C.; Schoeps, K.-O.; Stone-Elander, S.; Wiezel, F.-A. The Bucherer-Strecker synthesis of D-(1-C-11)tyrosine and L-(1-C-11)tyrosine and the invivo study of L-(1-C-11)tyrosine in human brain using positron emission tomography. Eur. J. Nucl. Med., 1987, 13, 288-291.
53. Vaalburg, W.; Coenen, H.H.; Crouzel, C.; Elsinga, P.H.; Långström, B.; Lemaire, C.; Meyer, G.J. Amino acids for the measurement of protein synthesis in vivo by PET. Nucl. Med. Biol., 1992, 19, 227-237.
54. Machulla, H.-J.; Dutschka, K. C-11-labelled radiopharmaceuticals - synthesis and high pressure liguid chromatography of alpha-alanine-1-C-11. Radiochem. Radioamal. Letters, 1976, 25, 309-315.
55. Iwata, R.; Ido, T.; Takahashi, T.; Nakanishi, H.; Iida, S. Optimization of [11C]HCN production and no-carrier-added [1-11C]amino acid synthesis. Appl. Radiat. Isot., 1987, 38, 97-102.
56. Hayes, R.L.; Washburn, L.C.; Wieland, B.W.; Sun, T.T.; Anon, J.B.; Butler, T.A.; Callahan A.P. Synthesis and purification of carboxyl-C-11-labelled amino acids. Int. J. Appl. Radiat. Isot., 1978, 29, 186-187.
57. Casey, D.L.; Digenis, G.A.; Wesner, D.A.; Washburn, L.C.; Chaney, J.E.; Hayes, R.L.; Callahan, A.P. Preparation and preliminary tissue studies of optically active C-11-D-phenylalanine and L-phenylalanine. Int. J. Appl. Radiat. Isotop., 1981, 32, 325-330.
58. Antoni, G.; Långström, B. Synthesis of DL-[3-C-11]valine using [2-C-11]isopropyl iodide, and preparation of L-[3-C-11]valine by treatment with D-amino acid oxidase. Int. J. Appl. Radiat. Isotop., 1987, 38, 655-659.
59. Ding, Y.-S., Antoni, G.; Fowler, J.S.; Wolf, A.P.; Långström, B. Synthesis of L-[5-C-11]ornithine. J. Labelled Compd. Radiofarm., 1989, 32, 1079-1090.
60. Långström, B.; Stridsberg, B. Synthesis of racemic [alanine-1-C-11] and partially resolved [alanine-3-C-11]. Int. J. Appl. Radiat. Isot., 1979, 30, 151-153.
61. Antoni, G.; Långström, B. Asymmetric synthesis of L-[3-C-11]alanine. Acta Chem. Scand., 1986, B40, 152-156.
62. Antoni, G.; Långström, B. Asymmetric synthesis of L-2-amino[3-C-11]butyric acid, L-[3-C-11]norvaline and L-[3-C-11]valine. Acta Chem. Scand., 1987, B41, 511-517.
63. Jeanjean, F.; Fournet, G.; Le Bars, D.; Gore J. Synthesis of highly enantioenriched alpha-amino acids by carboxylation of N-(alphalithioalkyl)oxazolidinones. Eur. J. Org. Chem., 2000, 1297-1305.
64. Oppolzer, W.; Moretti, R.; Zhou C. Asymmetric alkylation of a sultamderived glycine equivalent - practical preparation of enantiomerically pure alpha-amino acids. Helv. Chim. Acta, 1994, 77, 2363-2380.
65. Knight, C.G. Stereospecific synthesis of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid, an alternative to tryptophan in quenched fluorescent substrates for peptidases. Lett. Pept. Sci., 1998, 5, 1-4.
66. Lankiewicz, L.; Barthélémy, N.; Fransson, B.; Grehn, L.; Ragnarsson, U. Synthesis of amino acid derivatives substituted in the backbone with stable isotopes for application in peptide synthesis. J. Chem. Soc., Perkin Trans 1, 1994, 2503-2510.
67. th International Symposium on Radiopharmaceutical Chemistry, Uppsala, Sweden, June 15 - 19, 1997. J. Labelled Compd. Radiofarm., 1997, 40, 758-759.
68. Seebach, D.; Sting, A.R.; Hoffmann, M. Self-regeneration of stereocenters (SRS) - Applications, limitations, and abandonment of a synthetic principle. Angew. Chem., Int. Ed. Engl., 1996, 35, 2708-2748.
69. Plenevaux, A.; Al-Darwich, M.J.; Lemaire, C.; Delfiore, G.; Comar, D. Enantioselective synthesis of n.c.a. (S)-L-[beta-C-11]-4-chlorophenylalanine and (S)-L-(alpha-methyl)-[beta-C-11]-4-chlorophenylalanine. Appl. Radiat. Isot., 1994, 45, 361-369.
70. Fasth, K.J.; Hörnfeldt, K.; Långström B. Asymmetric synthesis of C-11 labeled L-amino and D-amino acids by alkylation of imidazolidinone derivatives. Acta Chem. Scand., 1995, 49, 301-304.
71. Seebach, D.; Hoffmann M. Preparation and use in amino acid synthesis of a new chiral glycine derivative - (R)-and (S)-tert-butyl 2-tert-butyl-4-methoxy-2,5-dihydroimidazole-1-carboxylate (BDI). Eur. J. Org. Chem. 1998, 1337-1351.
72. Crich, D.; Davies, J.W. Asymmetric synthesis of alpha-alkylated tryptophan derivatives. J. Chem. Soc., Chem. Commun., 1989, 1418-1419.
73. Bourne, G.T.; Crich, D.; Davies, J.W.; Horwell, D.C. Enantiospecific synthesis with amino acids. 1. Tryptophan as a chiron for the synthesis of alphasubstituted tryptophan derivatives. J. Chem. Soc., Perkin Trans. 1, 1991, 1693-1699.
74. Plenevaux, A.; Lemaire, C.; Delfiore, G.; Comar, D. Enantioselective synthesis of NCA (S)-L-([alpha-C-11]methyl)tryptophan. Appl. Radiat. Isot., 1994, 45, 651-653.
75. 18F-labelled enantiomerically pure alpha-amino acids. Dalton Trans., 2012, 41, 1430-1440.
76. 13C-monolabelled alpha-aminoisobutyric acid. J. Radioanal. Nucl. Chem., 2010, 285, 621-626.
77. 13C-NMR spectra of the complex. Collect. Czech. Chem. Commun., 2005, 70, 1397-1410.
78. Kilbourn, M.R.; Dischino, D.D.; Welch, M.J. Synthesis of DL-[3-11C]phenylalanine. Int. J. Appl. Radiat. Isot., 1984, 35, 603-605.
79. Antoni, G.; Långström, B. Synthesis of racemic [3-C-11]-labeled alanine, 2-aminobutyric acid, norvaline, norleucine, leucine and phenylalanine and preparation of L-[3-C-11]alanine and L-[3-C-11]phenylalanine. J. Labelled Compd. Radiofarm., 1987, 24, 125-143.
80. th International Symposium on Radiopharmaceutical Chemistry, Uppsala, Sweden, June 15 - 19, 1997, J. Labelled Compd. Radiofarm. 1997, 40, 760-761.
81. Ooi, T.; Takeuchi, M.; Kameda, M.; Maruoka, K. Practical catalytic enantioselective synthesis of alpha, alpha-dialkyl-alpha-amino acids by chiral phase-transfer catalysis. J. Am. Chem. Soc., 2000, 122, 5228-5229.
82. For a review see: Ooi, T.; Maruoka K. Recent advances in asymmetric phasetransfer catalysis. Angew. Chem. Int. Ed., 2007, 46, 4222-4266.
83. Fitt, J.J.; Gschwend, H.W. Alpha-alkylation and Michael addition of amino acids - a practical method. J. Org. Chem., 1977, 42, 2639-2641.
84. Chaly, T.; Diksic, M. Synthesis of no-carrier-added alpha-[C-11]methyl-Ltryptophan. J. Nucl. Med., 1988, 29, 370-374.
85. Suehiro, M.; Ravert, H.T.; Wilson, A.A.; Scheffel, U.; Dannals, R.F.; Wagner Jr., H.N. Further investigation on the radiosynthesis of alpha-[C-11]methyl tryptophan. J. Labelled Compd. Radiofarm., 1992, 31, 151-157.
86. Rajagopal, S.; Venkatachalam, T.K.; Conway, T.; Diksic, M. Synthesis of C-14-labeled alpha-methyl tyrosine. Appl. Radiat. Isot., 1992, 43, 979-987.
87. Krasikova, R.N.; Zaitsev, S.M.; Ametamey, S.M.; Kuznetsova, O.F.; Fedorova, O.S.; Mosevich, I.K.; Belokon, Y.N.; Vyskoçil Š., Shatik, S.V.; Nader, M.; Schubiger, P.A. Catalytic enantio selective synthesis of F-18-fluorinated alpha-amino acids under phase-transfer conditions using (S)-NOBIN. Nucl. Med. Biol., 2004, 31, 597-603.
88. Cohen, M.B.; Spolter, L.; Chang, C.C.; Behrendt, D.; Cook, J.; MacDonald, N.S. The varying tissue distribution of L-glutamic acid labelled at 3 different sites. Int. J. Appl. Radiat. Isotop., 1982, 33, 613-617.
89. Barrio, J.R.; Egbert, J.E.; Henze, E.; Schelbert, H.R.; Baumgartner, F.J. L-[4-C-11]Labeled aspartic acid - enzymatic synthesis, myocardial uptake, and metabolism. J. Med. Chem., 1982, 25, 93-96.
90. Halldin, C.; Långström, B. Synthesis of [3-C-11]phenylpyruvic acid and its use in an enzymatic transamination to [3-C-11]phenylalanine. J. Labelled Compd. Radiofarm., 1986, 23, 715-722.
91. Svård, H.; Jigerius, S.B.; Långström, B. The enzymatic synthesis of L-[3-C-11]serine. Appl. Radiat. Isotop., 1990, 41, 587-591.
92. Bjurling, P.; Watanabe, Y.; Långström, B. The synthesis of [3-C-11]pyruvic acid, a useful synthon, via an enzymatic route. Appl. Radiat. Isotop., 1988, 39, 627-630.
93. Bjurling, P.; Watanabe, Y.; Malmborg, P.; Långström, B. Multi-enzymatic synthesis of some carbon-11 labelled neurotransmitter precursors tyrosine, DOPA, tryptophan and 5-hydroxytryptophan. J. Labelled Compd. Radiofarm., 1989, 26, 243-245.
94. Bjurling, P.; Watanabe, Y.; Tokushide, M.; Långström, B. Synthesis of beta-C-11-labeled L-tryptophan and 5-hydroxy-L-tryptophan using a multienzymatic reaction route. J. Chem. Soc., Perkin Trans. 1, 1989, 1331-1334.
95. Bjurling, P.; Watanabe, Y.; Oka, S.; Nasagawa, T.; Yamada, H.; Långström, B. Multienzymatic synthesis of beta-C-11-labeled L-tyrosine and L-DOPA. Acta Chem. Scand., 1990, 44, 183-188.
96. Bjurling, P.; Malmborg, P.; Långström, B. Enzymatic syntheses of some carbon-11-labelled analogues of L-tyrosine and L-tryptophan. J. Labelled Compd. Radiofarm., 1991, 30, 399-400.
97. Antoni, G.; Omura, H.; Bergström, M.; Sundin, A.; Watanabe, Y.; Långström, B. Synthesis of 4-11C-labelled L-aspartic acid, L-asparagine and L-2,4-diaminobutyric acid from enzymatically produced beta-(11C)cyanoalanine. J. Labelled Compd. Radiofarm., 1995, 37, 182-183.
98. Gee, A.D.; Långström, B. The synthesis of alpha-([C-11]methyl)phenylalanine and alpha-([C-11]methyl)tyrosine from C-11 labeled malonic esters. J. Chem. Soc., Perkin Trans. 1, 1991, 215-218.
99. Labarre, J.; Donie, P.; Crouzel, C. The biosynthesis of L-[C-11]phenylalanine using a mutant strain of a cyanobacterium (Synechocystis PCC-6803). Appl. Radiat. Isotop., 1991, 42, 659-663.
100. Halldin, C.; Långström, B. Synthesis of racemic [3-C-11]phenylalanine and [3-C-11]DOPA. Int. J. Appl. Radiat. Isotop., 1984, 35, 779-782.
101. Halldin, C.; Långström, B. Asymmetric synthesis of [3-C-11] L-phenylalanine using chiral hydrogenation catalysts. Int. J. Appl. Radiat. Isotop., 1984, 35, 945-948.
102. Halldin, C. PhD Thesis, Uppsala University, Acta Universitatis Upsaliensis 1984.
103. Nagel, U.; Albrecht, J. The enantioselective hydrogenation of Nacyldehydroamino acids. Topics in Catalysis, 1998, 5, 3-23.
104. 11C-methylation of homocisteine residue in a peptide. Int. J. Appl. Radiat. Isot., 1976, 27, 357-360.
105. Lundquist, P.; Hartvig, P.; Blomquist, G.; Hammarlund-Udenaes, M.; Långström, B. 5-hydroxy-L-[beta-C-11]tryptophan versus alpha-[C-11]methyl-L-tryptophan for positron emission tomography imaging of serotonin synthesis capacity in the rhesus monkey brain. J. Cereb. Blood Flow Metab., 2007, 27, 821-830.
106. Sakai, Y.; Nishikawa, M.; Leyton, M.; Benkelfat, C.; Young, S.N.; Diksic, M. Cortical trapping of alpha-[C-11]methyl-L-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage, 2006, 33, 815-824.
107. Natsume, J.; Kumakura, Y.; Bernasconi, N.; Soucy, J.P.; Nakai, A.; Rosa, P.; Fedi, M.; Dubeau, F.; Andermann, F.; Lisbona, R.; Bernasconi, A.; Diksic, M. Alpha-[C-11]methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology, 2003, 60, 756-761.
108. Fedi, M.; Reutens, D.; Okazawa, H.; Andermann, F.; Boling, W.; Dubeau, F.; White, C.; Nakai, A.; Gross, D.W.; Andermann, E.; Diksic M. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology, 2001, 57, 1629-1636.
109. Diksic, M. Labelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system. J. Psychiatry Neurosci., 2001, 26, 293-303.
110. Nishizawa, S.; Benkelfat, C.; Young, S.N.; Leyton, M.; Mzengeza, S.; DeMontigny, C.; Blier, P.; Diksic, M. Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. USA, 1997, 94, 5308-5313.
111. Diksic, M. Alpha-methyl tryptophan as a tracer for in-vivo studies of brain serotonin system, from autoradiography to positron emission tomography. J. Chem. Neuroanat. 1992, 5, 349-354.
112. Visser, A.K.D.; van Waarde, A.; Willemsen, A.T.M.; Bosker, F.J.; Luiten, P.G.M.; den Boer, J.A.; Kema, I.P.; Dierckx, R.A.J.O. Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications. Eur. J. Nucl. Med. Mol. Imaging, 2011, 38, 576-591.
113. Shoaf, S.E.; Carson, R.E.; Hommer, D.; Williams, W.A.; Higley, J.D.; Schmall, B.; Herscovitch, P.; Eckelman, W.C.; Linnoila, M. The suitability of [C-11]-alpha-methyl-L-tryptophan as a tracer for serotonin synthesis: Studies with dual administration of [C-11] and [C-14] labeled tracer. J. Cereb. Blood Flow Metab., 2000, 20, 244-252.
114. Shah, U; Giubellino, A; Pacak, K. Pheochromocytoma: implications in tumorigenesis and the actual management. Minerva Endocrinologica, 2012, 37, 141-156.
115. Pacak, K. Approach to the patient - Preoperative management of the pheochromocytoma patient. The Journal of Clinical Endocrinology & Metabolism, 2007, 92, 4069-4079.
116. Manger, W.M. In search of pheochromocytomas. The Journal of Clinical Endocrinology & Metabolism, 2003, 88, 4080-4082.
117. Inoue, T.; Tomiyoshi, K.; Higuichi, T.; Ahmed, K.; Sarwar, M.; Aoyagi, K.; Amano, S.; Alyafei, S.; Zhang, H.N.; Endo K. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: A potential tumor-detecting agent. J. Nucl. Med., 1998, 39, 663-667.
118. Kaira, K.; Oriuchi, N.; Otani, Y.; Shimizu, K.; Tanaka, S.; Imai, H.; Yanagitani, N.; Sunaga, N.; Hisada, T.; Ishizuka, T.; Dobashi, K.; Kanai, Y.; Endou, H.; Nakajima, T.; Endo, K.; Mori, M. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: A clinicopathologic study. Clinical Cancer Research, 2007, 13, 6369-6378.
119. Jager, P.L.; Meijer, W.G.; Kema, I.P.; Willemse, P.H.; Piers, D.A.; de Vries, E.G. L-3-[I-123]iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: Correlation with biochemical activity and comparison with [In-111-DTPA-D-Phe(1)]-octreotide imaging. J. Nucl. Med., 2000, 41, 1793-1800.
120. Shikano, N.; Kanai, Y.; Kawai, K.; Inatomi, J.; Kim, D.K.; Ishikawa, N.; Endou, H. Isoform selectivity of 3-I-125-iodo-alpha-methyl-L-tyrosine membrane transport in human L-type amino acid transporters. J. Nucl. Med., 2003, 44, 244-246.
121. Lahoutte, T.; Caveliers, V.; Camargo, S.M.R.; Franca, R.; Ramadan, T.; Veljkovic, E.; Mertens, J.; Bossuyt, A.; Verrey, F. SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. J. Nucl. Med., 2004, 45, 1591-1596.
122. Sjoerdsma, A.; Engelman, K.; Spector, S.; Udenfriend, S. Inhibition of catecholamine synthesis in man with alpha-methyl tyrosine an inhibitor of tyrosine hydroxylase. Lancet, 1965, 2, 1092.
123. Engelman, K.; Horwitz, D.; Jéquier, E.; Sjoerdsma, A. Biochemical and pharmacologic effects of alpha-methyltyrosine in man. J. Clin. Iinvestigation, 1968, 47, 577-594.
124. Brogden, R.N.; Heel, R.C.; Speight, T.M.; Avery, G.S. Alpha-methyl-paratyrosine - a review of its pharmacology and clinical use. Drugs, 1981, 21, 81-89.
125. Chirakal, R.; Vasdev, N.; Asselin, M.-C.; Schrobilgen, G.J.; Nahmias, C. The effect of aromatic fluorine substitution in L-DOPA on the in vivo behaviour of [F-18]2-, [F-18]5-and [F-18]6-fluoro-L-DOPA in the human brain. J. Fluor. Chem., 2002, 115, 33-39.
126. Melega, W.P.; Luxen, A.; Perlmutter, M.M.; Nissenson, C.H.K.; Phelps, M.E.; Barrio, J.R. Comparative in-vivo metabolism of 6-[F-18]fluoro-L-DOPA and [H-3] L-DOPA in rats. Biochemical Pharmacology, 1990, 39, 1853-1860.
127. Yee, R.E.; Cheng, D.W.; Huang, S.-C.; Namavari M., Satyamurthy N., Barrio J.R. Blood-brain barrier and neuronal membrane transport of 6-[F-18]fluoro-L-DOPA Biochemical Pharmacology, 2001, 62, 1409-1415.
128. Timmers, H.J.L.M.; Taieb, D.; Pacak, K. Current and Future Anatomical and Functional Imaging Approaches to Pheochromocytoma and Paraganglioma. Hormone and Metabolic Research, 2012, 44, 367-372.
129. For review see: Oberg, K. Molecular imaging in diagnosis of neuroendocrine tumours. Lancet Oncology, 2006, 7, 790-792.
130. For review see: Groves, A.M.; Win, T.; Ben Haim, S.; Ell, P.J. Non-[18F]FDG PET in clinical oncology. Lancet Oncology, 2007, 8, 822-830.
131. For review see: Sundin, A.; Garske, U.; Orlefors, H. Nuclear imaging of neuroendocrine tumours. Best Practice & Research Clinical Endocrinology & Metabolism, 2007, 21, 69-85.
132. For review see: Seibyl, J.P.; Chen, W.; Silverman, D.H.S. 3,4-dihydroxy-6-[F-18]-fluoro-L-phenylaianine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors. Sem. Nucl. Med., 2007, 37, 440-450.
133. 11C)-L-DOPA following COMT inhibition - a study in-vivo using positron emission tomography. J. Neural Transmission-General Section, 1992, 87, 15-22.
134. For a review see: Cumming, P.; Gjedde, A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse, 1998, 29, 37-61.
135. Ames, M.M.; Melmon, K.L.; Castagnoli, N. Stereochemical course in-vivo of alpha-methyldopa decarboxylation in rat brains. Biochemical Pharmacology, 1977, 26, 1757-1762.
136. 11C]methylsubstituted aromatic alpha-amino acids - a challenge of creation of quaternary asymmetric centre in a very short time. J. Labelled Compd. Radiopharm., 2007, 50, 370-374.
137. For a review see: Myhre, E.; Rugstad, H.E.; Hansen, T. Clinical pharmacokinetics of methyldopa. Clinical Pharmacokinetics, 1982, 7, 221-233.
138. Yost, Y.; Conway, T. Synthesis and preliminary evaluation of (S)-(2-[F-18]fluoro-4,5-dihydroxyphenyl)-2-methyl L-alanine, (S)-[F-18]FMEDOPA, a potentially improved imaging agent for the presynaptic dopaminergic nervous system. Nucl. Med. Biol., 1996, 23, 857-865.
139. For a review see: Duthaler, R.O. Recent development in the stereoselective synthesis of alpha-amino acids. Tetrahedron, 1994, 50, 1539-1650.
140. For a review see: Bailey, P.D.; Clayson, J.; Boa, A.N, a&alpha-Cation equivalents of amino acids. Contemp. Org. Synth., 1995, 2, 173-187.
141. For a review see: Cativiela, C.; Días-de-Villegas, M.D. Stereoselective synthesis of quaternary alpha-amino acids. Part 1: Acyclic compounds. Tetrahedron: Asymmetry, 1998, 9, 3517-3599.
142. For a review see: Cativiela, C.; Días-de-Villegas, M.D. Stereoselective synthesis of quaternary alpha-amino acids. Part 2. Cyclic compounds. Tetrahedron: Asymmetry, 2000, 11, 645-732.
143. For a review see: Ohfune, Y.; Shinada T. Enantio-and diastereoselective construction of alpha, alpha-disubstituted alpha-amino acids for the synthesis of biologically active compounds. Eur. J. Org. Chem., 2005, 5127-5143.
144. For a review see: Vogt, H.; Bräse, S. Recent approaches towards the asymmetric synthesis of alpha, alpha-disubstituted alpha-amino acids. Org. Biomol. Chem., 2007, 7, 406-430.
145. For a review see: Najera, C.; Sansano, J.M. Catalytic asymmetric synthesis of alpha-amino acids. Chem. Rev., 2007, 107, 4584-4671.
146. For a review see: Cativiela, C.; Días-de-Villegas, M.D. Recent progress on the stereoselective synthesis of acyclic quaternary alpha-amino acids. Tetrahedron: Asymmetry, 2007, 18, 569-623.
147. Cativiela, C.; Ordonez, M. Recent progress on the stereoselective synthesis of cyclic quaternary alpha-amino acids. Tetrahedron: Asymmetry, 2009, 20, 1-63.
148. Quaternary Stereocenters - Challenges and Solutions for Organic Synthesis, Christoffers, J.; Baro, A., Eds.; Wiley-VCH: Weinheim, 2005.